Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic β-cells

Diabetes, Obesity and Metabolism

Volumn 10, Issue 7, 2008, Pages 564-573

  Saitoh, Y ^a   Chun ping, C ^a   Noma, K ^a   Ueno, H ^a   Mizuta, Masanari ^a   Nakazato, M ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

NF kB; Palmitate; PPARg; Reactive oxygen species; Type 2 diabetes; cell lipoapoptosis

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; INSULIN; MESSENGER RNA; PALMITIC ACID; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL LEVEL; CELL SURVIVAL; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION REGULATION; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 45449118936     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2007.00749.x     Document Type: Article

References (47)

1. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995; 83: 803-812.
2. Lehmann JM, Moore LB, Smith-Oliver TA et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ(PPARγ). J Biol Chem 1995; 270: 12953-12956.
3. Berger J, Bailey P, Biswas C et al. Thiazolidindiones produce a conformational change in peroxisomal proliferator-activated receptor-γ: Binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 1996; 137: 4189-4195.
4. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994; 331: 1188-1193.
5. Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest 1997; 100: 530-537.
6. Prigeon RL, Kahn SE, Porte DJ. Effect of troglitazone on β-cell function, insulin sensitivity, and glycemic control in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 819-823.
7. Shimabukuro M, Zhou YT, Lee Y, Unger RH. Troglitazone lowers islet fat and restores β cell function of Zucker diabetic fatty rats. J Biol Chem 1998; 273: 3547-3550.
8. De Souza CJ, Yu JH, Robinson DD, Ulrich RG, Meglasson MD. Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance. Diabetes 1995; 44: 984-991.
9. Diani AR, Sawada G, Wyse B, Murray FT, Khan M. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes. Am J Physiol Endocrinol Metab 2004; 286: E116-E122.
10. Kubo K. Effect of pioglitazone on blood proinsulin levels in patients with type 2 diabetes mellitus. Endocr J 2002; 49: 323-328.
11. Miyazaki Y, Matsuda M, De Fronzo RA. Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes. Diabetes Care 2002; 25: 517-523.
12. Lupi R, Del Guerra S, Marselli L et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: Evidence for a role of PPARγ2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 2004; 286: E560-E567.
13. Higa M, Zhou YT, Ravazzola M, Baetens D, Orci L, Unger RH. Troglitazone prevents mitochondrial alterations, β cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci USA 1999; 96: 11513-11518.
14. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci USA 1998; 95: 2498-2502.
15. Finegood DT, Mc-Arthur MD, Kojwang D et al. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 2001; 50: 1021-1029.
16. Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 2001; 50: 1771-1777.
17. Fleury C, Neverova M, Collins S et al. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997; 15: 269-272.
18. Ricquier D, Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J 2000; 345: 161-179.
19. Zhou YP, Grill VE. Palmitate-induced β-cell insensitivity to glucose is coupled to decreased pyruvate dehydrogenase activity and enhanced kinase activity in rat pancreatic islets. Diabetes 1995; 44: 394-399.
20. Unger RH, Zhou YT. Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001; 50: S118-S121.
21. Chandra J, Zhivotovsky B, Zaitsev S, Juntti-Berggren L, Berggren PO, Orrenius S. Role of apoptosis in pancreatic β-cell death in diabetes. Diabetes 2001; 50: S44-S47.
22. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16: 35-39.
23. Minami K, Yokokura M, Ishizuka N, Seino S. Normalization of intracellular Ca 2+ induces a glucose-responsive state in glucose-unresponsive β-cells. J Biol Chem 2002; 277: 25277-25282.
24. Detimary P, Van den Berghe G, Henquin JC. Concentration dependence and time course of the effects of glucose on adenine and guanine nucleotides in mouse pancreatic islets. J Biol Chem 1996; 271: 20559-20565.
25. Cnop M, Hannaert JC, Pipeleers DG. Troglitazone dose not protect rat pancreatic β cells against free fatty acid-induced cytotoxicity. Biochem Pharmacol 2002; 63: 1281-1285.
26. Rothe G, Emmendorffer A, Oser A, Roesler J, Valet G. Flow cytometric measurement of the respiratory burst activity of phagocytes using dihydrorhodamine 123. J Immunol Methods 1991; 138: 133-135.
27. Chan CB, De Leo D, Joseph JW et al. Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion: Mechanism of action. Diabetes 2001; 50: 1302-1310.
28. Chan CB, Mac Donald PE, Saleh MC, Jones DC, Marban E, Wheeler MB. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes 1999; 48: 1482-1486.
29. Sako Y, Grill VE. A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 1990; 127: 1580-1589.
30. Zhou YP, Grill VE. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 1994; 93: 870-876.
31. Unger RH, Zhou YT, Orci L. Regulation of fatty acid homeostasis in cells: Novel role of leptin. Proc Natl Acad Sci USA 1999; 96: 2327-2332.
32. Pahan K, Sheikh FG, Khan M, Namboodiri AM, Singh I. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J Biol Chem 1998; 273: 2591-2600.
33. Wang N, Verna L, Chen NG et al. Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 2002; 277: 34176-34181.
34. Chung SW, Kang BY, Kim SH et al. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB. J Biol Chem 2000; 275: 32681-32687.
35. Schlezinger JJ, Jensen BA, Mann KK, Ryu HY, Sherr DH. Peroxisome proliferator-activated receptor γ-mediated NF-κB activation and apoptosis in pre-B cells. J Immunol 2002; 169: 6831-6841.
36. Chang I, Kim S, Kim JY et al. Nuclear factor κB protects pancreatic β-cells from tumor necrosis factor-α-mediated apoptosis. Diabetes 2003; 52: 1169-1175.
37. Maedler K, Sergeev P, Ris F et al. Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110: 851-860.
38. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J. Adiponectin counteracts cytokine-and fatty acid-induced apoptosis in the pancreatic β-cell line INS-1. Diabetologia 2004; 47: 249-258.
39. Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL. Free fatty acids and cytokines induce pancreatic β-cell apoptosis by different mechanisms: Role of nuclear factor-κB and endoplasmic reticulum stress. Endocrinology 2004; 145: 5087-5096.
40. Johnson JD, Han Z, Otani K et al. RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatric islets. J Biol Chem 2004; 279: 24794-24802.
41. Long YC, Barnes BR, Mahlapuu M et al. Role of AMP-activated protein kinase in the coordinated expression of genes controlling glucose and lipid metabolism in mouse white skeletal muscle. Diabetologia 2005; 48: 2354-2364.
42. Ishida H, Takizawa M, Ozawa S et al. Pioglitazone improves insulin capacity and prevents the loss of β-cell mass in obese diabetic db/ db mice: Possible protection of β cells from oxidative stress. Metabolism 2004; 53: 488-492.
43. Leonid EF, Louis HP. Does the glucose-dependent insulin secretion mechanism itself cause oxidative stress in pancreatic β-cells? Diabetes 2004; 53: 1942-1948.
44. Tsubouchi H, Inoguchi T, Inuo M et al. Sulfonylurea as well as elevated glucose levels stimulate reactive oxygen species production in the pancreatic β-cell line, MIN6-a role of NAD(P)H oxidase in β-cells. Biochem Biophys Res Commun 2005; 326: 60-65.
45. Ohtani KI, Shimizu H, Sato N, Mori M. Troglitazone (CS-045) inhibits β-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells. Endocrinology 1998; 139: 172-178.
46. Nakamichi Y, Kikuta T, Ito E et al. PPAR-γ overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells. Biochem Biophys Res Commun 2003; 306: 832-836.
47. Li LX, Skorpen F, Egeberg K, Jorgensen IH, Grill V. Uncoupling protein-2 participates in cellular defense against oxidative stress 47 in clonal β-cells. Biochem Biophys Res Commun 2001; 282: 273-277.